Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |